Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Yang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2739-1916; OpenAlex author ID A5100354659. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 6

  1. The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome. Co-author DOI 10.1038/s41598-025-12651-x↗
  2. Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway. Co-author DOI 10.1007/s10620-021-07262-1↗
  3. Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. Co-author DOI 10.1186/s13045-022-01286-4↗
  4. Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Co-author DOI 10.3389/fonc.2021.630972↗
  5. Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy. Co-author DOI 10.3892/ol.2018.8701↗
  6. HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. Co-author PMID 31949740↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lin Liang · 1 shared paper, 2025 · strength 0.28
  2. Xia Yuan · 1 shared paper, 2025 · strength 0.28
  3. Lu Zhuang · 2 shared papers, 2018–2022 · strength 0.24
  4. Kun Lin · 2 shared papers, 2018–2022 · strength 0.24
  5. Lisi Peng · 2 shared papers, 2018–2022 · strength 0.24
  6. Xinglong Geng · 1 shared paper, 2021 · strength 0.13
  7. Yongwei Wang · 1 shared paper, 2021 · strength 0.13
  8. Guanqun Li · 1 shared paper, 2021 · strength 0.13
  9. Wenbo Yang · 1 shared paper, 2021 · strength 0.13
  10. Hongze Chen · 1 shared paper, 2021 · strength 0.13
  11. Le Li · 1 shared paper, 2021 · strength 0.13
  12. Tao Zhang · 1 shared paper, 2021 · strength 0.13
  13. Bei Sun · 1 shared paper, 2021 · strength 0.13
  14. Huamin Wang · 1 shared paper, 2022 · strength 0.12
  15. Tushar Damodar Bhagat · 1 shared paper, 2022 · strength 0.12
  16. Anirban Maitra · 1 shared paper, 2022 · strength 0.12
  17. Amit K. Verma · 1 shared paper, 2022 · strength 0.12
  18. Xiao‐Qiang Li · 1 shared paper, 2018 · strength 0.11
  19. Jingyu Qian · 1 shared paper, 2018 · strength 0.11
  20. Yulin Tan · 1 shared paper, 2018 · strength 0.11
  21. Zhaoshen Li · 1 shared paper, 2018 · strength 0.08
  22. Kaixuan Wang · 1 shared paper, 2018 · strength 0.08
  23. Haojie Huang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.